Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Oxalobacter formigenes strain HC-1

EU orphan designation number: EU/3/06/354   
Active ingredient: Oxalobacter formigenes strain HC-1
Indication: Treatment of primary hyperoxaluria
Sponsor: OxThera AB
Sturegatan 56, 114 36, Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/02/2006 Orphan designation EMEA/OD/095/05 (2006)558 of 17/02/2006
17/08/2011 Change of name and/or address of sponsor EMEA/OD/095/05
04/02/2013 Change of name and/or address of sponsor